Benzbromarone

DB12319ApprovedWithdrawnSmall molecule

Benzbromarone is a uricosuric agent which is taken daily for the prevention of gout flares. Benzbromarone has been used in trials studying the basic science and treatment of Heart Failure, Hyperuricemia, Chronic Kidney Disease, Abnormal Renal Function, and Gout and Asymptomatic Hyperuricemia.

Chemical structure of Benzbromarone
Mechanism
Curator reviewed
Formula / weight
C17H12Br2O3 · 424.083 g/mol (avg)
Code names
L-2214 · MJ 10061

Resolves to

Clinical / RWD
Structure
InChIKeyWHQCHUCQKNIQEC-UHFFFAOYSA-NSMILESCCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=CC=CC=C2O1

What you can answer from here — as of June 15, 2026

5Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
3TransportersSubstrate / inhibitor direction, not just membership
Listed above
789Drug interactionsStructured to mechanism, not free text
Sign in
10Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
4Marketed productsAcross 3 countries and 3 labellers
Sign in
1ATC codeIncluding every combination product, plus 17 drug categories
Sign in
29+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Benzbromarone, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account